vs
CF Industries（CF）与英格索兰（IR）财务数据对比。点击上方公司名可切换其他公司
英格索兰的季度营收约是CF Industries的1.1倍（$2.1B vs $2.0B），CF Industries净利率更高（31.0% vs 12.7%，领先18.2%），CF Industries同比增速更快（19.4% vs 10.1%），CF Industries自由现金流更多（$1.7B vs $461.5M），过去两年CF Industries的营收复合增速更高（12.4% vs 11.9%）
CF Industries Holdings Inc.是美国知名农用肥料生产及分销商，1946年成立时名为中央农民肥料公司，总部位于芝加哥郊区的伊利诺伊州诺斯布鲁克。公司主营氨、尿素、硝酸铵等肥料产品，最初为区域农业供应合作社联盟，成立56年后完成股份化改制，转为公开上市企业。
英格索兰是一家美国跨国企业，主营流体生产及工业产品业务。公司于2020年2月由原英格索兰plc的工业业务板块分拆后与加德纳丹佛合并组建，旗下拥有40多个品牌，产品覆盖全球所有主要市场。
CF vs IR — 直观对比
营收规模更大
IR
是对方的1.1倍
$2.0B
营收增速更快
CF
高出9.3%
10.1%
净利率更高
CF
高出18.2%
12.7%
自由现金流更多
CF
多$1.2B
$461.5M
两年增速更快
CF
近两年复合增速
11.9%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $2.0B | $2.1B |
| 净利润 | $615.0M | $266.1M |
| 毛利率 | 37.6% | 42.6% |
| 营业利润率 | 43.5% | 18.7% |
| 净利率 | 31.0% | 12.7% |
| 营收同比 | 19.4% | 10.1% |
| 净利润同比 | 97.1% | 15.8% |
| 每股收益（稀释后） | $3.98 | $0.67 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CFIR
| Q1 26 | $2.0B | — | ||
| Q4 25 | $1.9B | $2.1B | ||
| Q3 25 | $1.7B | $2.0B | ||
| Q2 25 | $1.9B | $1.9B | ||
| Q1 25 | $1.7B | $1.7B | ||
| Q4 24 | $1.5B | $1.9B | ||
| Q3 24 | $1.4B | $1.9B | ||
| Q2 24 | $1.6B | $1.8B |
净利润CFIR
| Q1 26 | $615.0M | — | ||
| Q4 25 | $495.0M | $266.1M | ||
| Q3 25 | $460.0M | $244.1M | ||
| Q2 25 | $492.0M | $-115.3M | ||
| Q1 25 | $351.0M | $186.5M | ||
| Q4 24 | $392.0M | $229.8M | ||
| Q3 24 | $341.0M | $221.6M | ||
| Q2 24 | $506.0M | $185.0M |
毛利率CFIR
| Q1 26 | 37.6% | — | ||
| Q4 25 | 40.9% | 42.6% | ||
| Q3 25 | 38.1% | 43.7% | ||
| Q2 25 | 39.9% | 43.7% | ||
| Q1 25 | 34.4% | 44.6% | ||
| Q4 24 | 34.4% | 42.9% | ||
| Q3 24 | 32.4% | 43.8% | ||
| Q2 24 | 43.2% | 43.9% |
营业利润率CFIR
| Q1 26 | 43.5% | — | ||
| Q4 25 | 33.0% | 18.7% | ||
| Q3 25 | 35.0% | 19.2% | ||
| Q2 25 | 34.3% | 4.0% | ||
| Q1 25 | 27.4% | 17.6% | ||
| Q4 24 | 28.9% | 20.0% | ||
| Q3 24 | 26.6% | 19.1% | ||
| Q2 24 | 40.6% | 15.1% |
净利率CFIR
| Q1 26 | 31.0% | — | ||
| Q4 25 | 26.4% | 12.7% | ||
| Q3 25 | 27.7% | 12.5% | ||
| Q2 25 | 26.0% | -6.1% | ||
| Q1 25 | 21.1% | 10.9% | ||
| Q4 24 | 25.7% | 12.1% | ||
| Q3 24 | 24.9% | 11.9% | ||
| Q2 24 | 32.2% | 10.2% |
每股收益（稀释后）CFIR
| Q1 26 | $3.98 | — | ||
| Q4 25 | $2.56 | $0.67 | ||
| Q3 25 | $2.19 | $0.61 | ||
| Q2 25 | $2.37 | $-0.29 | ||
| Q1 25 | $1.85 | $0.46 | ||
| Q4 24 | $1.86 | $0.57 | ||
| Q3 24 | $1.55 | $0.54 | ||
| Q2 24 | $2.30 | $0.45 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $1.2B |
| 总债务越低越好 | $3.2B | $4.8B |
| 股东权益账面价值 | $5.3B | $10.1B |
| 总资产 | $14.6B | $18.3B |
| 负债/权益比越低杠杆越低 | 0.60× | 0.47× |
8季度趋势，按日历期对齐
现金及短期投资CFIR
| Q1 26 | — | — | ||
| Q4 25 | — | $1.2B | ||
| Q3 25 | — | $1.2B | ||
| Q2 25 | — | $1.3B | ||
| Q1 25 | — | $1.6B | ||
| Q4 24 | — | $1.5B | ||
| Q3 24 | — | $1.4B | ||
| Q2 24 | — | $1.1B |
总债务CFIR
| Q1 26 | $3.2B | — | ||
| Q4 25 | $3.2B | $4.8B | ||
| Q3 25 | $3.0B | $4.8B | ||
| Q2 25 | $3.0B | $4.8B | ||
| Q1 25 | $3.0B | $4.8B | ||
| Q4 24 | $3.0B | $4.8B | ||
| Q3 24 | $3.0B | $4.8B | ||
| Q2 24 | $3.0B | $4.8B |
股东权益CFIR
| Q1 26 | $5.3B | — | ||
| Q4 25 | $4.8B | $10.1B | ||
| Q3 25 | $4.8B | $10.1B | ||
| Q2 25 | $5.0B | $10.1B | ||
| Q1 25 | $4.8B | $10.5B | ||
| Q4 24 | $5.0B | $10.2B | ||
| Q3 24 | $5.2B | $10.3B | ||
| Q2 24 | $5.5B | $10.0B |
总资产CFIR
| Q1 26 | $14.6B | — | ||
| Q4 25 | $14.1B | $18.3B | ||
| Q3 25 | $14.2B | $18.2B | ||
| Q2 25 | $13.8B | $18.1B | ||
| Q1 25 | $13.3B | $18.4B | ||
| Q4 24 | $13.5B | $18.0B | ||
| Q3 24 | $13.8B | $18.2B | ||
| Q2 24 | $13.8B | $17.8B |
负债/权益比CFIR
| Q1 26 | 0.60× | — | ||
| Q4 25 | 0.66× | 0.47× | ||
| Q3 25 | 0.61× | 0.47× | ||
| Q2 25 | 0.60× | 0.47× | ||
| Q1 25 | 0.62× | 0.45× | ||
| Q4 24 | 0.60× | 0.47× | ||
| Q3 24 | 0.57× | 0.47× | ||
| Q2 24 | 0.54× | 0.48× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $496.0M | $499.0M |
| 自由现金流经营现金流 - 资本支出 | $1.7B | $461.5M |
| 自由现金流率自由现金流/营收 | 83.2% | 22.1% |
| 资本支出强度资本支出/营收 | 11.2% | 1.8% |
| 现金转化率经营现金流/净利润 | 0.81× | 1.88× |
| 过去12个月自由现金流最近4个季度 | $3.0B | $1.2B |
8季度趋势，按日历期对齐
经营现金流CFIR
| Q1 26 | $496.0M | — | ||
| Q4 25 | $539.0M | $499.0M | ||
| Q3 25 | $1.1B | $354.6M | ||
| Q2 25 | $563.0M | $245.7M | ||
| Q1 25 | $586.0M | $256.4M | ||
| Q4 24 | $420.0M | $526.2M | ||
| Q3 24 | $931.0M | $404.0M | ||
| Q2 24 | $475.0M | $304.9M |
自由现金流CFIR
| Q1 26 | $1.7B | — | ||
| Q4 25 | $313.0M | $461.5M | ||
| Q3 25 | $717.0M | $325.5M | ||
| Q2 25 | $318.0M | $210.4M | ||
| Q1 25 | $454.0M | $222.7M | ||
| Q4 24 | $223.0M | $490.9M | ||
| Q3 24 | $792.0M | $374.3M | ||
| Q2 24 | $391.0M | $283.1M |
自由现金流率CFIR
| Q1 26 | 83.2% | — | ||
| Q4 25 | 16.7% | 22.1% | ||
| Q3 25 | 43.2% | 16.6% | ||
| Q2 25 | 16.8% | 11.1% | ||
| Q1 25 | 27.3% | 13.0% | ||
| Q4 24 | 14.6% | 25.9% | ||
| Q3 24 | 57.8% | 20.1% | ||
| Q2 24 | 24.9% | 15.7% |
资本支出强度CFIR
| Q1 26 | 11.2% | — | ||
| Q4 25 | 12.1% | 1.8% | ||
| Q3 25 | 20.9% | 1.5% | ||
| Q2 25 | 13.0% | 1.9% | ||
| Q1 25 | 7.9% | 2.0% | ||
| Q4 24 | 12.9% | 1.9% | ||
| Q3 24 | 10.1% | 1.6% | ||
| Q2 24 | 5.3% | 1.2% |
现金转化率CFIR
| Q1 26 | 0.81× | — | ||
| Q4 25 | 1.09× | 1.88× | ||
| Q3 25 | 2.31× | 1.45× | ||
| Q2 25 | 1.14× | — | ||
| Q1 25 | 1.67× | 1.37× | ||
| Q4 24 | 1.07× | 2.29× | ||
| Q3 24 | 2.73× | 1.82× | ||
| Q2 24 | 0.94× | 1.65× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CF
| EBITDA | $1.0B | 51% |
| Other | $975.0M | 49% |
| Loss on foreign currency transactions | $3.0M | 0% |
IR
| Transferred At Point In Time | $1.5B | 71% |
| Transferred Over Time | $193.0M | 9% |
| Precision And Science Technologies Segment | $183.1M | 9% |
| Acquisitions In2024 | $175.6M | 8% |
| Acquisitions In2025 | $70.8M | 3% |
